Qualitative analysis evaluates policy frameworks influencing innovation and entrepreneurship in Poland, indicating challenges ahead.
This paper explores Poland’s evolving policy frameworks and strategic initiatives aimed at fostering innovation and entrepreneurship, within the context of economic transformation and integration into the European Union (EU). Utilising qualitative document analysis, the study evaluates both macro level strategies and micro level mechanisms that support the development of start-ups and higher value-added sectors. Using policy documents, institutional reports, and academic literature, the analysis identifies key instruments such as the Smart Growth Operational Programme, the Fast Track initiative, and the IP Box tax incentive, that work alongside major institutions such as the Polish Agency for Enterprise Development (PARP) and the National Centre for Research and Development (NCBR). Two illustrative case studies, Ryvu Therapeutics and SDS Optic, demonstrate the tangible outcomes of these initiatives in enabling product innovation, attracting investment, and facilitating global market expansion. While the paper recognises Poland’s progress in building an innovation-oriented economy, it also highlights persistent challenges, including fragmented institutional structures, limited industry academia collaboration, and an underdeveloped venture capital ecosystem. Guided by theoretical insights from Wennekers & Thurik (1999), Carree & Thurik (2010), and Urbano et al (2019), the paper argues that financial investment must be complemented by deeper institutional reform to unlock the full potential of entrepreneurship. The findings contribute to policy discourse in transition economies by offering a foundation for future empirical evaluations and proposing strategies for building a coherent, inclusive, and globally competitive innovation system.
No takes yet. Share an insight, caveat, or question.
Malcolm Galt (2025) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: